These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18438546)

  • 1. Clinical experience with an implanted closed-loop insulin delivery system.
    Renard E
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):349-54. PubMed ID: 18438546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.
    Renard E; Costalat G; Chevassus H; Bringer J
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):497-502. PubMed ID: 17130808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas.
    Renard E; Place J; Cantwell M; Chevassus H; Palerm CC
    Diabetes Care; 2010 Jan; 33(1):121-7. PubMed ID: 19846796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.
    Ly TT; Roy A; Grosman B; Shin J; Campbell A; Monirabbasi S; Liang B; von Eyben R; Shanmugham S; Clinton P; Buckingham BA
    Diabetes Care; 2015 Jul; 38(7):1205-11. PubMed ID: 26049550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithm.
    Feichtner F; Mader JK; Schaller R; Schaupp L; Ellmerer M; Korsatko S; Kondepati VR; Heise HM; Wilinska ME; Hovorka R; Pieber TR
    J Diabetes Sci Technol; 2011 Jul; 5(4):901-5. PubMed ID: 21880232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances toward the implantable artificial pancreas for treatment of diabetes.
    Jaremko J; Rorstad O
    Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable continuous glucose sensors.
    Renard E
    Curr Diabetes Rev; 2008 Aug; 4(3):169-74. PubMed ID: 18690897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm Real-Time System.
    Pohar SL
    Issues Emerg Health Technol; 2007 Oct; (105):1-6. PubMed ID: 17953047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.
    Young AJ; Thabit H; Heller SR; Evans ML; Amiel SA; Hovorka R; Barnard KD
    J Diabetes Sci Technol; 2015 Jul; 9(4):932-3. PubMed ID: 25852073
    [No Abstract]   [Full Text] [Related]  

  • 16. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sub-cutaneous closed-loop: continuous glucose measurement and external insulin pump: hope in treatment of type 1 diabetes].
    Puech-Bret N; Hanaire H
    Ann Endocrinol (Paris); 2007 Jun; 68 Suppl 1():21-7. PubMed ID: 17961657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.